104 related articles for article (PubMed ID: 2743496)
1. The conjugative metabolism of 4-methylumbelliferone and deconjugation to the parent drug examined by isolated perfused liver and in vitro liver homogenate of rats.
Miyauchi S; Sugiyama Y; Iga T; Hanano M
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):475-80. PubMed ID: 2743496
[TBL] [Abstract][Full Text] [Related]
2. Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.
Miyauchi S; Sugiyama Y; Iga T; Hanano M
J Pharm Sci; 1988 Aug; 77(8):688-92. PubMed ID: 3210158
[TBL] [Abstract][Full Text] [Related]
3. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
Ratna S; Chiba M; Bandyopadhyay L; Pang KS
Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.
Miyauchi S; Sugiyama Y; Sawada Y; Morita K; Iga T; Hanano M
J Pharmacokinet Biopharm; 1987 Feb; 15(1):25-38. PubMed ID: 3305862
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.
Morita K; Sugiyama Y; Hanano M
J Pharmacobiodyn; 1986 Feb; 9(2):117-24. PubMed ID: 3712212
[TBL] [Abstract][Full Text] [Related]
6. Effect of flow on first-pass metabolism of drugs: single pass studies on 4-methylumbelliferone conjugation in the serially perfused rat intestine and liver preparations.
Chen J; Pang KS
J Pharmacol Exp Ther; 1997 Jan; 280(1):24-31. PubMed ID: 8996177
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of 4-methylumbelliferyl sulfate in periportal and pericentral areas of the liver lobule.
Anundi I; Kauffman FC; el-Mouelhi M; Thurman RG
Arch Toxicol; 1987; 60(1-3):69-72. PubMed ID: 3619646
[TBL] [Abstract][Full Text] [Related]
8. Conjugative metabolism of 4-methylumbelliferone in the rat liver: verification of the sequestration process in multiple indicator dilution experiments.
Miyauchi S; Sugiyama Y; Sawada Y; Iga T; Hanano M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4241-8. PubMed ID: 3325180
[No Abstract] [Full Text] [Related]
9. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of 4-methylumbelliferone in mice.
Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacobiodyn; 1987 May; 10(5):195-200. PubMed ID: 3625453
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
Wettstein M; Gerok W; Häussinger D
Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
[TBL] [Abstract][Full Text] [Related]
12. Glucuronidation and sulfation in the rat in vivo. The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone.
Mulder GJ; Brouwer S; Weitering JG; Scholtens E; Pang KS
Biochem Pharmacol; 1985 Apr; 34(8):1325-9. PubMed ID: 3994749
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
Anundi IM; Kauffman FC; el-Mouelhi M; Thurman RG
Mol Pharmacol; 1986 Jun; 29(6):599-605. PubMed ID: 3713703
[TBL] [Abstract][Full Text] [Related]
14. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
Pang KS; Cherry WF; Terrell JA; Ulm EH
Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
[TBL] [Abstract][Full Text] [Related]
15. Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.
Hansel SB; Morris ME
J Pharmacokinet Biopharm; 1996 Apr; 24(2):219-43. PubMed ID: 8875348
[TBL] [Abstract][Full Text] [Related]
16. Effect of protein binding on 4-methylumbelliferyl sulfate desulfation kinetics in perfused rat liver.
Chiba M; Pang KS
J Pharmacol Exp Ther; 1993 Aug; 266(2):492-9. PubMed ID: 8355186
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of drugs. I: studies by in vivo constant infusion.
Ishii M; Kanayama M; Esumi H; Ogawara KI; Kimura T; Higaki K
Xenobiotica; 2002 May; 32(5):441-50. PubMed ID: 12065065
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and clearance of T-2 mycotoxin in perfused rat livers.
Pace JG
Fundam Appl Toxicol; 1986 Oct; 7(3):424-33. PubMed ID: 3781132
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers.
Parasrampuria R; Mehvar R
Xenobiotica; 2008 Oct; 38(10):1263-73. PubMed ID: 18798123
[TBL] [Abstract][Full Text] [Related]
20. Studies on increased bile formation produced by polyoxybenzenes in rats.
Tanayama S; Kanai Y
Jpn J Pharmacol; 1977 Feb; 27(1):71-8. PubMed ID: 864884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
